- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05058664
Developing Text-based Support for Parents of Adolescents After an Emergency Department Visit
April 18, 2024 updated by: Ewa Czyz, University of Michigan
Developing Text-based Support for Parents of Suicidal Adolescents After Emergency Department Visits: A Multi-component Intervention Pilot
The researchers seek to develop a text message intervention for caregivers of adolescents at elevated suicide risk following discharge from emergency department (ED) care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants in the trial included 120 youth-parent dyads (120 youths and 120 parents).
As the ultimate focus of the intervention is on improving youth outcomes, participant-related descriptives are provided for youth participants, except where noted specifically to be parent-related data.
Study Type
Interventional
Enrollment (Actual)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- The University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Parent eligibility:
Inclusion Criteria:
- Parent of eligible teen
Exclusion Criteria:
- Not owning a cell phone with text messaging capability.
Teen eligibility:
Inclusion Criteria:
- Recent suicidal ideation (within last 2 weeks) and/or suicide attempt within the last month.
Exclusion Criteria:
- Youth with severe cognitive impairment or altered mental status (e.g., psychosis, manic state)
- Youth with severe aggression/agitation
- No availability of a legal guardian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control (standard care)
|
|
Experimental: A-F texting component
The A-F texting component will include content consistent with best-practice recommendations for parents to buffer youth against suicide risk.
|
Over the course of the 6-week intervention parents in the A-F condition will receive 1 message each day.
|
Experimental: A-F texting plus P-F texting component
A-F texting plus P-F texting component arm includes the A-F component, as above, and P-F component.
The P-F component includes an embedded micro-randomized trial (MRT) involving two daily randomizations to P-F message vs. no message conditions for the duration of the 6-week intervention.
Participants who are randomized to this arm will be randomized twice each day (morning and evening) to either receive or not receive the P-F message at each randomization.
|
Over the course of the 6-week intervention parents in the A-F condition will receive 1 message each day.
Over the course of the 6 week intervention, parents will receive between 1-2 messages, depending on randomization (in addition to A-F component messages)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Eligible Youth-Parent Dyads Who Agree to Participate in the Study,
Time Frame: At the time of youth Emergency Department visit
|
Data represent participant dyads who were eligible and approached about study participation, and who agreed to take part in the study.
|
At the time of youth Emergency Department visit
|
Participant Dyads Who Completed Follow-up Assessments
Time Frame: Up to 12 weeks
|
Data was used to determine retention rate among the participant dyads.
We report on follow up completion for both adolescent and caregiver members of the dyad.
|
Up to 12 weeks
|
Percentage of Participants Randomized to the Intervention Who Remained Active (Texting Arms Only)
Time Frame: Up to 6 weeks
|
Results represent parent participants who did not request stopping the intervention (i.e., did not request to stop receiving messages).
|
Up to 6 weeks
|
Participating Parents' Satisfaction With the Intervention (Texting Arms Only)
Time Frame: Up to 6 weeks
|
Measured using the Modified Client Satisfaction Questionnaire (CSQ), which was a 2-question survey.
Each question had a range of 1-4.
Adult participants were asked to rate both their overall satisfaction (1 meaning not satisfied to 4 meaning highly satisfied), and the likelihood that they would recommend their particular assigned intervention to a friend (1 meaning highly unlikely to 4 meaning highly likely).
|
Up to 6 weeks
|
Number of and Reasons for Active Withdrawals
Time Frame: Up to 12 weeks
|
Parent participant request to withdraw from the study.
Study intention was to collect the number of and reasons for withdrawals, but the sole withdrawal did not provide a reason.
|
Up to 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ewa Czyz, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 8, 2021
Primary Completion (Actual)
September 26, 2022
Study Completion (Actual)
September 26, 2022
Study Registration Dates
First Submitted
September 16, 2021
First Submitted That Met QC Criteria
September 16, 2021
First Posted (Actual)
September 28, 2021
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
April 18, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00184110
- 1R34MH124767-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Vestre Viken Hospital TrustSouth-Eastern Norway Regional Health AuthorityActive, not recruitingEcological Momentary Assessment | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionNorway
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
VA Office of Research and DevelopmentNot yet recruitingSuicidal Ideation | Suicide Attempt | Suicide PreventionUnited States
-
Franciscan Hospital For Children, INC.National Institute of Mental Health (NIMH); Harvard UniversityRecruitingSuicidal Ideation | Self-Injurious Behavior | Suicide AttemptsUnited States
-
Mental Health Services in the Capital Region, DenmarkCompletedSuicide Prevention | Suicidal Thoughts | Suicide AttemptsDenmark
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
-
Boston UniversityUnited States Department of Defense; The University of Texas Health Science... and other collaboratorsNot yet recruiting
Clinical Trials on A-F texting component
-
Bausch Health Americas, Inc.CompletedAcne VulgarisUnited States, Canada
-
Università degli Studi di FerraraCompleted
-
University of AmsterdamNetherlands Organisation for Scientific ResearchNot yet recruiting
-
City University of New YorkNot yet recruitingIntersectional Stigma
-
Bausch Health Americas, Inc.CompletedAcne VulgarisUnited States, Canada
-
Sunnybrook Health Sciences CentreCancer Care OntarioCompleted
-
Boehringer IngelheimCompleted
-
University of ValenciaRecruitingPhysical Activity | Music Intervention | Fundamental Motor SkillsSpain
-
Valeant PharmaceuticalsUnknown
-
Gamaleya Research Institute of Epidemiology and...Research Institute of Influenza, Sankt-Peterburg, Russian FederationCompletedHealthy VolunteersRussian Federation